No registrations found.
ID
Source
Brief title
Health condition
Glaucoma, laser treatment, glaucoom, laser behandeling
Sponsors and support
Intervention
Outcome measures
Primary outcome
time to redo SLT
Secondary outcome
IOP control after primary and secondary SLT
Background summary
SLT has proven to be a viable alternative for medication in the treatment of glaucoma patients. Like argon laser trabeculoplasty, its effect seems to lower in time. Its repeatability is therefore important. We ai mto investigate how long it takes for the efect of SLT wears off and whether a second SLT is as effective as the first SLT to lower IOP.
Study objective
1, the effect of SLT diminishes in time; how fast does IOP get below target IOP after SLT?
2, is a repeat SLT effective to get/keep IOP under target IOP?
3, is there a racial difference in effect of SLT?
Study design
baseline, 1 week, 3, 6, 12, 18, 24, 30, 36, 42, 48, 60 months
Intervention
1, redo of SLT when target IOP is exceeded by more than 2 mmHg when IOP was controlled at least 6 months after intial SLT
2, control group under medication
Inclusion criteria
Patients with ocular hypertension or open angle glaucoma.Other types of glaucoma than open angle glaucoma, corneal disease that inhibit good visualization of the trabecular meshwork, taking of systemic or local steroids.
Exclusion criteria
Other types of glaucoma than open angle glaucoma, corneal disease that inhibit good visualization of the trabecular meshwork, taking of systemic or local steroids.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL6144 |
| NTR-old | NTR6299 |
| Other | : NTR5417 |
Summary results
DOI 10.1186/s40662-016-0041-y
De Keyser M. Power is not energy. Letter to the Editor. Journal of Glaucoma, May 5, 2016. Doi:10.1097/IJG.0000000000000432
De Keyser M, De Belder M, De Groot V. Randomized prospective study of the use of anti-inflammatory drops after selective laser trabeculoplasty. Journal of Glaucoma, 26(2), e22-e29.doi:10.1097/IJG.0000000000000522.
De Keyser M, De Belder M, De Groot V. Selective laser trabeculoplasty in pseudophakic and phakic eyes: a prospective study. International Journal of Ophthalmology, 10;4:2017.
De Keyser M, De Belder M, De Groot V. Prospective study on the effect of selective laser trabeculoplasty in normal tension glaucoma. International Journal of Ophthalmology and Eye Science, S1:008, 36-41, 2016. IJOES-2332-290X-S1-008
De Keyser M, De Belder M, De Groot V. Treatment-related quality of life in glaucoma patients: comparison between selective laser trabeculoplasty and medication. International Journal of Ophthalmology, 10; 4: 2017.
De Keyser M, De Belder M, De Belder J, De Groot V. Effect of selective laser trabeculoplasty in glaucoma patients with high or low central corneal thickness. Insights in Ophthalmology, vol 1, 1:3, 2017.
De Keyser M, De Belder M, De Belder J, De Groot V. Selective laser trabeculoplasty as replacement therapy in medically controlled glaucoma patients. In submission.